PRANA Biotechnology Ltd

192 articles about PRANA Biotechnology Ltd

• PRANA Biotechnology Provides Clinical Trials Update

  8/22/2012

• PRANA Biotechnology's PBT2 Presented at the Huntington's Disease Society of America National Convention

  6/13/2012

• PRANA Biotechnology to Present at the UBS Australian Healthcare Conference in Sydney and the Australian Life Science Investment Showcase in New York

  6/1/2012

• PRANA Biotechnology Chief Scientific Advisor to Give Plenary Lecture at Alzheimer's Symposium in Stockholm Featuring New Targets and Drugs

  5/9/2012

• PRANA Biotechnology Comments on Archives of Neurology Publication Which Highlights Critical Role of Brain Metals in Huntington Disease Progression

  5/1/2012

• PRANA Biotechnology Enrolls First Patient in the "Reach2HD" Phase II Huntington Disease Trial

  4/30/2012

• PLoS ONE Journal Publishes Mechanistic Model of Alzheimer's Disease Endorsing PRANA Biotechnology's PBT2

  3/26/2012

• PRANA Biotechnology Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial

  3/7/2012

• PRANA Biotechnology Comments on Nature Medicine, Proceedings of the National Academy of Sciences and Journal of Alzheimer's Disease Articles That Highlight the Role of Metals in Neurological Diseases

  2/2/2012

• Professor Rudy Tanzi Appointed PRANA Biotechnology's Chief Scientific Advisor

  1/11/2012

• FDA Approval to Commence Huntington's Disease Clinical Trial Using PRANA Biotechnology's PBT2

  1/4/2012

• Landmark Publication Endorses PRANA Biotechnology's Drug Pipeline Strategy for Treating Neurodegenerative Diseases

  12/16/2011

• PRANA Biotechnology Commences Alzheimer's Trial Recruitment

  12/15/2011

• PRANA Biotechnology Secures Key Patent for Parkinson's Drug PBT434 in the United States

  11/28/2011

• PRANA Biotechnology Receives Approval for Alzheimer's Trial

  11/22/2011

• PRANA Biotechnology's PBT2 Reverses the Loss of Synaptic Activity in Neurons

  11/14/2011

• Australian Federal Government Funds Study Into Neuroprotective Benefits of PRANA Biotechnology's PBT2

  10/27/2011

• PRANA Biotechnology Release: Australian Federal Government Grant to Study Effect of PBT2 in the Aging Brain

  10/21/2011

• PRANA Biotechnology's PBT2 Directly Restores Neurons Critical to Cognition

  9/19/2011

• PRANA Biotechnology's Planned Huntington's Trial Receives Strong Interest from Patients and Researchers

  9/15/2011